Is Rocket Lab the next great defense-space compounder? Or is it just a prettier version of the same cash-incinerating growth story investors have been burned by before?

Right now, it’s both. And the difference between those outcomes hinges on one word: execution.

Rocket Lab just put up $602m in 2025 revenue, up 38% year over year. Q4 alone hit $180m. Backlog swelled to $1.85B — up 73%. That’s not a science project. That’s traction. The $816m Space Development Agency contract to build missile-tracking satellites is the kind of prime award that changes how the Pentagon sees you. Add in inclusion in the $5.6B National Security Space Launch Phase 3 program, and Rocket Lab isn’t a scrappy small-launch shop anymore. It’s in the club.

And that’s the bull case in a nutshell: Rocket Lab is quietly becoming a vertically integrated defense-space contractor. Launch (Electron, soon Neutron), spacecraft buses, components, full satellite builds. Recurring government demand. Multi-year programs. High switching costs. If this machine scales, you don’t get a meme stock — you get a compounding defense franchise.

But here’s the part bulls gloss over: this thing still bleeds.

2025 GAAP net loss: ~$198m.

Operating cash flow: negative ~$165m.

Investing cash flow: negative ~$347m.

Q4 alone burned ~$64m from operations.

Yes, they’ve got ~$829m in cash. Yes, they raised over $1B through equity. But that’s dilution paying for hope. The Neutron rocket — the real step-up vehicle that gets them into heavier payloads and bigger national security missions — is delayed to Q4 2026 after a tank test failure. Delays in rockets aren’t minor scheduling hiccups. They’re cost multipliers.

And Neutron matters. Electron is reliable and impressive (21 successful missions in 2025, 100% success rate), but small launch isn’t where the defense money scales. Medium lift is. If Neutron slips again, the narrative shifts from “emerging prime” to “perpetual development story.”

Now, here’s why Rocket Lab isn’t just another SPAC ghost.

First: revenue quality is improving. Space Systems — building satellites and components — is a steadier, less binary business than pure launch. That smooths cash flow over time.

Second: the backlog isn’t fluff. Missile tracking satellites for the Space Force aren’t speculative science payloads. They’re tied to geopolitical reality. And geopolitical reality isn’t getting calmer.

Third: they’re winning as a prime contractor, not just a subcontractor. That’s margin power if they execute. It also signals trust from the Department of Defense — the stickiest customer in America.

But this is not yet a defense compounder. Lockheed and Northrop compound because they generate cash. Rocket Lab consumes it. A compounder funds growth internally. Rocket Lab funds it with dilution and hope for milestone payments.

The bet on RKLB today is simple: can they flip from heavy investment mode to disciplined program execution before the cash cushion thins and capital markets get less friendly?

If Neutron flies in 2026 and performs, the valuation multiple will look conservative in hindsight. If delays stack up and burn stays elevated, this becomes another “almost there” space stock.

So which is it?

Rocket Lab has crossed the line from speculative launch startup to serious defense contender. That’s real. But it hasn’t crossed the line to self-sustaining prime contractor. Not yet.

Investors need to stop asking whether it’s a space company and start asking whether it can become a cash-flow defense business. Because that’s the fork in the road.

Neutron’s launch window isn’t just a technical milestone. It’s the moment we find out if Rocket Lab compounds — or combusts.

#RocketLabFuture #DefenseTech #SpaceInnovation #CashFlowChallenge #NeutronLaunch #AerospaceInvesting #GovernmentContracts #HighStakesExecution #StartupToContender #InvestmentRisk